Ultrasound in Evaluation of Preoperative Fluid Management of Hip Fracture Surgery Patients
NCT ID: NCT05916599
Last Updated: 2023-06-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
70 participants
OBSERVATIONAL
2023-01-03
2023-09-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Point-of-care Gastric Ultrasound for Fracture Surgery
NCT05728242
Measurement of Cut-off Perfusion Index Value in Infraclavicular Blocks
NCT05234541
Pilot Implementation of the Postoperative Hypothermia Management Care Bundle
NCT06829017
Fluid Responsiveness in Prone Position
NCT05401526
Hemoglobin-to-red Blood Cell Distribution Width Ratio and Hypothermia for Elderly Patient
NCT06790017
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1.The inferior vena cava collapse index IVC CI and lung ultrasound score (LUS) measurements and goal directed fluid therapy will be done 2. Group applying zero balance liquid therapy to patients with conventional methods is planned.
1. Patients in the group will be started with fluid replasment at an hourly rate of 2ml/kg/h and with ultrasound measurement the infused fluid will be evaluated and regulated.
2. Crystalloid liquid infusion at a rate of 2ml/kg/hour will be administered to the patients in the group additional fluid replacement will be decided by monitoring bleeding and urinary output, zero balance is aimed at patients. Both groups were treated with spinal anesthesia in the postoperative period 120. minute IVC CI and the LUS score value will be checked.
If the CI is below 50% and the LUS score is below 15, fluid management will be considered as successful.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_CONTROL
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Goal directed
The inferior vena cava collapse index IVC CI and lung ultrasound score (LUS) measurements and goal directed fluid therapy will be done.Patients in the group will be started with fluid replasment at an hourly rate of 2ml/kg/h and with ultrasound measurement the infused fluid will be evaluated and regulated.
ultrasound
a device which is used in intensive care units,
conventional
. Group applying zero balance liquid therapy to patients with conventional methods is planned. Crystalloid liquid infusion at a rate of 2ml/kg/hour will be administered to the patients in the group additional fluid replacement will be decided by monitoring bleeding and urinary output, zero balance is aimed at patients.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ultrasound
a device which is used in intensive care units,
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I-II-III patients
Exclusion Criteria
* Patients with ASA IV-V
* Patients with BMI\>above 35
* Patients with an Lus score of 15 and above
* Patients who have not undergone spinal anesthesia
65 Years
110 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Gaziosmanpasa Research and Education Hospital
OTHER_GOV
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Döndü Genc Moralar
head of anesthesiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
zuhal çavuş, MD
Role: PRINCIPAL_INVESTIGATOR
gaziosmanpasa TREH
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Gaziosmanpasa Education and Research Hospital
Istanbul, Gaziosmanpaşa, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
138
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.